Journal of Cardiovascular Imaging

  • 제24권2호
  • /
  • Pages.104-105
  • /
  • 2016
  • /
  • 2586-7210(pISSN)
  • /
  • 2586-7296(eISSN)
한국심초음파학회 (Korean Society of Echocardiography)
권호 표지
DOI QR코드

DOI QR Code

Neutrophil-to-Lymphocyte Ratio for Risk Assessment in Coronary Artery Disease and Carotid Artery Atherosclerosis

  • Park, Jun-Bean (Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital)
  • 투고 : 2016.05.30
  • 심사 : 2016.05.31
  • 발행 : 2016.06.27
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 2014;11:276-89. https://doi.org/10.1038/nrcardio.2014.26
  2. Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries, Board on Global Health, Institute of Medicine. Promoting cardiovascular health in the developing world: a critical challenge to achieve global health. Washington, DC: National Academies Press;2010.
  3. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74. https://doi.org/10.1038/nature01323
  4. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95. https://doi.org/10.1056/NEJMra043430
  5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97. https://doi.org/10.1056/NEJMoa032804
  6. Engstrom G, Hedblad B, Stavenow L, Tyden P, Lind P, Janzon L, Lindgarde F. Fatality of future coronary events is related to inflammationsensitive plasma proteins: a population-based prospective cohort study. Circulation 2004;110:27-31. https://doi.org/10.1161/01.CIR.0000133277.88655.00
  7. Kim BJ, Cho SH, Cho KI, Kim HS, Heo JH, Cha TJ. The combined impact of neutrophil-to-lymphocyte ratio and type 2 diabetic mellitus on significant coronary artery disease and carotid artery atherosclerosis. J Cardiovasc Ultrasound 2016;24:115-22. https://doi.org/10.4250/jcu.2016.24.2.115
  8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of Creactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65. https://doi.org/10.1056/NEJMoa021993
  9. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. https://doi.org/10.1161/01.CIR.0000053730.47739.3C
  10. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5. https://doi.org/10.1016/S0735-1097(98)00136-3
  11. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, Neumann FJ. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002;105:1412-5. https://doi.org/10.1161/01.CIR.0000012625.02748.62
  12. Bhatt DL, Topol EJ. Need to test the arterial inflammation hypothesis. Circulation 2002;106:136-40. https://doi.org/10.1161/01.CIR.0000021112.29409.A2
  13. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year followup of 14 719 initially healthy American women. Circulation 2003;107: 391-7. https://doi.org/10.1161/01.CIR.0000055014.62083.05
  14. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-7. https://doi.org/10.1001/jama.288.8.980
  15. C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011; 342:d548. https://doi.org/10.1136/bmj.d548
  16. Brunner EJ, Kivimaki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP, Shah T, Humphries SE, Hingorani AD, Marmot MG, Timpson NJ, Kumari M. Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream. PLoS Med 2008;5:e155. https://doi.org/10.1371/journal.pmed.0050155